PhD Studentship: Preclinical modelling and therapeutic targeting of glioblastoma infiltrative margin
UK Visa Sponsorship Analytics
Analytics are greyed out due to low classification confidence (41.0%).
Occupation Type
Other skilled trades not elsewhere classified.
Occupation Code Skill LevelMedium Skilled
Sponsorship EligibilityIneligible for Sponsorship
Above analytics are generated algorithmically based on job titles and may not always be the same as the company's job classification. You can also check detailed occupation eligibility, and salary criteria on our UK Visa Eligible Occupations & Salary Thresholds page.
Disclaimer: Hunt UK Visa Sponsors aggregates job listings from publicly available sources, such as search engines, to assist with your job hunting. We do not claim affiliation with University of Nottingham. For the most up-to-date job details, please visit the official website by clicking "Apply Now."
Description
Area
Medicine
Location
UK Other
Closing Date
Friday 01 May 2026
Reference
MED2046
PhD Studentship Advert
Title: Preclinical modelling and therapeutic targeting of glioblastoma infiltrative margin
Supervisors: Prof Ruman Rahman, Dr Stuart Smith, Dr Phoebe McCrorie
Project Overview:
Glioblastoma (GBM) is an incurable malignant brain tumour with severely limited therapeutic interventions and short survival times. Major challenges in treating GBM include intra-tumour heterogeneity and invasion into the adjacent healthy brain. Such invasive tumour subpopulations reflect residual disease intractable to standard multimodal treatment, and which is responsible for GBM recurrence. We have revealed distinct gene expression profiles of the infiltrative margin of glioblastoma via bulk transcriptomics https://pubmed.ncbi.nlm.nih.gov/37434262/ predicated on biopsies obtained via 5-aminolevulinic (5-ALA)-guided neurosurgery.
We now aim to resolve infiltrative margin biology at high resolution using single cell and spatial transcriptomic methods, to identify actionable therapy targets which could lead to informed delivery of personalised medicine approaches.
The appointed will work with genome, computational and cancer biologists at the University of Nottingham to develop and characterise patient-derived explant models amenable for drug repurposing studies. The project also introduces a collaboration with Queen’s Mary University, London, whereby 5ALA-negative astrocytes from the glioblastoma infiltrative margin will be re-programmed to generate induced pluripotent stem cells as a patient-matched toxicity control.
Research Environment:
Applications are invited for a 4-year fully-funded PhD studentship to join the University of Nottingham Brain Tumour Research Centre of Excellence (Director – Prof Ruman Rahman). The Centre is underpinned by 5-year programmatic funding from the charity ‘Brain Tumour Research (BTR)’ and represents a multidisciplinary and cross-Faculty research partnership, also leveraging international collaborators at University of Freiburg, Mayo Clinic Arizona, and Erasmus University Rotterdam. The hub of the Centre will be based at the Biodiscovery Institute (BDI) School of Medicine.
Eligibility:
Medicine
Location
UK Other
Closing Date
Friday 01 May 2026
Reference
MED2046
PhD Studentship Advert
Title: Preclinical modelling and therapeutic targeting of glioblastoma infiltrative margin
Supervisors: Prof Ruman Rahman, Dr Stuart Smith, Dr Phoebe McCrorie
Project Overview:
Glioblastoma (GBM) is an incurable malignant brain tumour with severely limited therapeutic interventions and short survival times. Major challenges in treating GBM include intra-tumour heterogeneity and invasion into the adjacent healthy brain. Such invasive tumour subpopulations reflect residual disease intractable to standard multimodal treatment, and which is responsible for GBM recurrence. We have revealed distinct gene expression profiles of the infiltrative margin of glioblastoma via bulk transcriptomics https://pubmed.ncbi.nlm.nih.gov/37434262/ predicated on biopsies obtained via 5-aminolevulinic (5-ALA)-guided neurosurgery.
We now aim to resolve infiltrative margin biology at high resolution using single cell and spatial transcriptomic methods, to identify actionable therapy targets which could lead to informed delivery of personalised medicine approaches.
The appointed will work with genome, computational and cancer biologists at the University of Nottingham to develop and characterise patient-derived explant models amenable for drug repurposing studies. The project also introduces a collaboration with Queen’s Mary University, London, whereby 5ALA-negative astrocytes from the glioblastoma infiltrative margin will be re-programmed to generate induced pluripotent stem cells as a patient-matched toxicity control.
Research Environment:
Applications are invited for a 4-year fully-funded PhD studentship to join the University of Nottingham Brain Tumour Research Centre of Excellence (Director – Prof Ruman Rahman). The Centre is underpinned by 5-year programmatic funding from the charity ‘Brain Tumour Research (BTR)’ and represents a multidisciplinary and cross-Faculty research partnership, also leveraging international collaborators at University of Freiburg, Mayo Clinic Arizona, and Erasmus University Rotterdam. The hub of the Centre will be based at the Biodiscovery Institute (BDI) School of Medicine.
Eligibility:
- BSc in cellular/molecular biology/biochemistry or related subject; MSc/MRes is desirable.
- Priority will be given to candidates with prior experience working with in vitro cancer models and associated drug inhibition assays.
- Those interested in applying should send a 2-page CV and 1-page cover letter to ruman.rahman@nottingham.ac.uk .
Anticipated start date: July 1 st , 2026.
Funding notes: This 4-year PhD studentship will include tuition fees for home students and an annual stipend equivalent to current UKRI rates (starting at £22,123).
Email details to a friend
View All Vacancies
View Previous List